Despite the introduction of many molecules targeting HER family of receptors, CDK4 and 6, PDL1, poly (ADP-ribose) polymerase (PARP), and PI3K/AKT pathway in breast cancer therapy [13], chemotherapy remains the first line of treatment in breast cancer treatment. This evidence concerns the gene CDK4 and breast cancer.